Loading
Latest filing published 09 Mar 2022 for Zogenix, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael P. Smith is a declared insider at 2 companies (finance chief); the most frequent names are Zogenix, Inc. and Raptor Pharmaceutical Corp. Over a trading history stretching from 9 February 2016 to 7 March 2022, the count stands at 24 filings.
Sales make up the whole of the open-market record (5 sales, €3.0M). Besides market trades, the filings include 7 share grants and 10 option exercises.
Most recently, on 9 March 2022, the filings show a transaction in Zogenix, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations